Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

NCT00004825 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.

NCT NCT00004825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
Lead sponsor
FDA Office of Orphan Products Development
Phase
Not applicable
Overall status
Completed
Start date
May 31, 1998
Completion date
May 31, 1998
Enrollment
10
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinism